Another finding that supports the pathophysiology of HC iron deposition is by Hoki et al,33 who, in their study of 40 Japanese patients with MASLD/MASH, reported that patients with MASH have upregulation of divalent metal transporters, even in the presence of elevated hepcidin. This evidence concerns the gene HAMP and metabolic dysfunction-associated steatotic liver disease.